Top 10 Medical AI Companies to Buy According to Analysts

8. Tempus AI, Inc. (NASDAQ:TEM)

Stock Upside Potential: 28.06%

Number of Hedge Fund Holders: 21

Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 medical AI companies to buy according to analysts. On July 16, the company confirmed that it had received clearance from the US Food and Drug Administration under the 510(k) process. The clearance is for the company’s Tempus ECG-Low EF software, designed to identify patients with a low left ventricular ejection fraction.

The AI-powered software is designed to measure the percentage of blood pumped out of each heartbeat. The software will be of great use for clinical diagnostics, ECG recordings collected at healthcare facilities.

“With Tempus ECG-Low EF, we’re adding another powerful tool to the hands of clinicians to help them identify patients at risk for serious cardiovascular conditions much earlier in their care journey,” said Brandon Fornwalt, Senior Vice President of Cardiology at Tempus.

It marks the second time Tempus AI has received FDA clearance for a cardiovascular product suite.

Tempus AI, Inc. (NASDAQ:TEM) is a technology company focused on precision medicine, utilizing artificial intelligence to enhance healthcare by improving disease diagnosis and treatment. It boasts a large library of clinical and genomic data to provide insights for healthcare professionals, aiming to personalize patient care and accelerate the development of new drugs.